Cargando…
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells
Blocking the immune evasion mechanism of tumor cells has become an attractive means for treating cancers. However, the usage of a drug such as nivolumab (αPD-1), which blocks programmed cell death protein 1 (PD-1), turned out to be only effective against certain types of cancer. Especially, vascular...
Autores principales: | Park, Songyi, Oh, Ji Hoon, Park, Dong Jin, Zhang, Haiying, Noh, Minyoung, Kim, Yeomyung, Kim, Ye-Seul, Kim, Hyejeong, Kim, Young-Myeong, Ha, Sang-Jun, Kwon, Young-Guen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874050/ https://www.ncbi.nlm.nih.gov/pubmed/33584714 http://dx.doi.org/10.3389/fimmu.2020.620166 |
Ejemplares similares
-
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
por: Kim, Ye-Seul, et al.
Publicado: (2020) -
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
por: Kim, Hyejeong, et al.
Publicado: (2023) -
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
por: Kim, Yeomyeong, et al.
Publicado: (2023) -
CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome
por: Park, Songyi, et al.
Publicado: (2023) -
CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury
por: Kim, Dong Young, et al.
Publicado: (2020)